BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 29301581)

  • 1. Activation of dopamine D1 receptor decreased NLRP3-mediated inflammation in intracerebral hemorrhage mice.
    Wang T; Nowrangi D; Yu L; Lu T; Tang J; Han B; Ding Y; Fu F; Zhang JH
    J Neuroinflammation; 2018 Jan; 15(1):2. PubMed ID: 29301581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine D1 receptor agonist A68930 attenuates acute kidney injury by inhibiting NLRP3 inflammasome activation.
    Cao JY; Zhou LT; Li ZL; Yang Y; Liu BC; Liu H
    J Pharmacol Sci; 2020 Jul; 143(3):226-233. PubMed ID: 32446726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine D1 receptor alleviates doxorubicin-induced cardiac injury by inhibiting NLRP3 inflammasome.
    Liu J; Jin Y; Wang B; Wang Y; Zuo S; Zhang J
    Biochem Biophys Res Commun; 2021 Jul; 561():7-13. PubMed ID: 33992835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoliquiritigenin alleviates early brain injury after experimental intracerebral hemorrhage via suppressing ROS- and/or NF-κB-mediated NLRP3 inflammasome activation by promoting Nrf2 antioxidant pathway.
    Zeng J; Chen Y; Ding R; Feng L; Fu Z; Yang S; Deng X; Xie Z; Zheng S
    J Neuroinflammation; 2017 Jun; 14(1):119. PubMed ID: 28610608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P2X7R blockade prevents NLRP3 inflammasome activation and brain injury in a rat model of intracerebral hemorrhage: involvement of peroxynitrite.
    Feng L; Chen Y; Ding R; Fu Z; Yang S; Deng X; Zeng J
    J Neuroinflammation; 2015 Oct; 12():190. PubMed ID: 26475134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NLRP3 is Required for Complement-Mediated Caspase-1 and IL-1beta Activation in ICH.
    Yao ST; Cao F; Chen JL; Chen W; Fan RM; Li G; Zeng YC; Jiao S; Xia XP; Han C; Ran QS
    J Mol Neurosci; 2017 Mar; 61(3):385-395. PubMed ID: 27933491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin reduces brain injury after intracerebral hemorrhage by reducing NLRP3 inflammasome expression.
    Wang S; Yao Q; Wan Y; Wang J; Huang C; Li D; Yang B
    Int J Neurosci; 2020 Mar; 130(3):301-308. PubMed ID: 31607194
    [No Abstract]   [Full Text] [Related]  

  • 8. Selective NLRP3 (Pyrin Domain-Containing Protein 3) Inflammasome Inhibitor Reduces Brain Injury After Intracerebral Hemorrhage.
    Ren H; Kong Y; Liu Z; Zang D; Yang X; Wood K; Li M; Liu Q
    Stroke; 2018 Jan; 49(1):184-192. PubMed ID: 29212744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cordycepin confers neuroprotection in mice models of intracerebral hemorrhage via suppressing NLRP3 inflammasome activation.
    Cheng Y; Wei Y; Yang W; Song Y; Shang H; Cai Y; Wu Z; Zhao W
    Metab Brain Dis; 2017 Aug; 32(4):1133-1145. PubMed ID: 28401330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NLRP3 inflammasome contributes to inflammation after intracerebral hemorrhage.
    Ma Q; Chen S; Hu Q; Feng H; Zhang JH; Tang J
    Ann Neurol; 2014 Feb; 75(2):209-19. PubMed ID: 24273204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment with low-dose fimasartan ameliorates NLRP3 inflammasome-mediated neuroinflammation and brain injury after intracerebral hemorrhage.
    Yang X; Sun J; Kim TJ; Kim YJ; Ko SB; Kim CK; Jia X; Yoon BW
    Exp Neurol; 2018 Dec; 310():22-32. PubMed ID: 30171865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
    Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
    Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ghrelin attenuates secondary brain injury following intracerebral hemorrhage by inhibiting NLRP3 inflammasome activation and promoting Nrf2/ARE signaling pathway in mice.
    Cheng Y; Chen B; Xie W; Chen Z; Yang G; Cai Y; Shang H; Zhao W
    Int Immunopharmacol; 2020 Feb; 79():106180. PubMed ID: 31926478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MST4 attenuates NLRP3 inflammasome-mediated neuroinflammation and affects the prognosis after intracerebral hemorrhage in mice.
    Wu X; Zhang Y; Zhang Y; Xia L; Yang Y; Wang P; Xu Y; Ren Z; Liu H
    Brain Res Bull; 2021 Dec; 177():31-38. PubMed ID: 34534636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FUNDC1 inhibits NLRP3-mediated inflammation after intracerebral hemorrhage by promoting mitophagy in mice.
    Zheng S; Jian D; Gan H; Wang L; Zhao J; Zhai X
    Neurosci Lett; 2021 Jun; 756():135967. PubMed ID: 34022268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-152 attenuates neuroinflammation in intracerebral hemorrhage by inhibiting thioredoxin interacting protein (TXNIP)-mediated NLRP3 inflammasome activation.
    Hu L; Zhang H; Wang B; Ao Q; He Z
    Int Immunopharmacol; 2020 Mar; 80():106141. PubMed ID: 31982825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effect of dexmedetomidine on intracerebral hemorrhage via regulating NLRP3.
    Song HL; Zhang SB
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2612-2619. PubMed ID: 30964190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine Receptor 1 Treatment Promotes Epithelial Repair of Corneal Injury by Inhibiting NOD-Like Receptor Protein 3-Associated Inflammation.
    Li L; Yu Y; Zhuang Z; Wu Q; Lin S; Hu J
    Invest Ophthalmol Vis Sci; 2024 Jan; 65(1):49. PubMed ID: 38294802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NLRP3 inhibitor, OLT1177 attenuates brain injury in experimental intracerebral hemorrhage.
    Fang M; Xia F; Wang J; Wang C; Teng B; You S; Li M; Chen X; Hu X
    Int Immunopharmacol; 2024 Apr; 131():111869. PubMed ID: 38492343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MitoQ attenuates brain damage by polarizing microglia towards the M2 phenotype through inhibition of the NLRP3 inflammasome after ICH.
    Chen W; Guo C; Huang S; Jia Z; Wang J; Zhong J; Ge H; Yuan J; Chen T; Liu X; Hu R; Yin Y; Feng H
    Pharmacol Res; 2020 Nov; 161():105122. PubMed ID: 32791262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.